Cytokine mRNA and protein expression in a mixed leukocyte reaction before and after allogeneic transfusions

Transplantation

Volumn 66, Issue 3, 1998, Pages 376-384

  Baudouin, Véronique ^a   Ansart Pirenne, Hélène ^a   Soulimani, Nabil ^a   Lang, Philippe ^b   Hiesse, Christian ^c   Sterkers, Ghislaine ^a  

^a HÔPITAL ROBERT DEBRÉ   (France)

^b HENRI MONDOR HOSPITAL   (France)

^c BICÊTRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4;

ADULT; ARTICLE; BLOOD TRANSFUSION; CELL TRANSFORMATION; CLINICAL ARTICLE; EPSTEIN BARR VIRUS; FEMALE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; KIDNEY TRANSPLANTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TREATMENT OUTCOME; VIRUS TRANSFORMATION;

EID: 0032529277     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199808150-00016     Document Type: Article

References (44)

1. Van der Kwast TH, Bianchi AT, Bril H, Benner R. Suppression of antigraft immunity by preimmunization. I. Kinetic aspects and specificity. Transplantation 1981; 31: 79.
2. Faustman D, Lacy P, Davie J, Hauptfeld V. Prevention of allograft rejection by immunization with donor blood depleted of Ia-bearing cells. Science 1982; 217: 157.
3. Singal DP, Ludwin D, Blajchman MA. Blood transfusion and renal transplantation. Br J Haematol 1985; 61: 595.
4. Rammensee HG, Fink PJ, Bevan MJ. Functional clonal deletion of class I-specific cytotoxic T lymphocytes by veto cells that express antigen. J Immunol 1984; 133: 2390.
5. Sano S, Suda T, Qian JH, Sato S, Ikegami R, Hamaoka T, Fujiwara H. Abrogation of the capacity of delayed-type hypersensitivity responses to alloantigens by intravenous injection of neuraminidase-treated allogeneic cells. J Immunol 1987; 139: 3652.
6. Dallman MJ, Shiho O, Page TH, Wood KJ, Morris PJ. Peripheral tolerance to alloantigen results from altered regulation of the interleukin 2 pathway. J Exp Med 1991; 173: 79.
7. Kalechman Y, Gafter U, Sobelman D, Sredni B. The effect of a single whole-blood transfusion on cytokine secretion. J Clin Immunol 1990; 10: 99.
8. Chen N, Field EH. Enhanced type 2 and diminished type 1 cytokines in neonatal tolerance. Transplantation 1995; 59: 933.
9. Gorczynski RM, Wojcik D. A role for non-specific (cyclosporin A) or specific (monoclonal antibodies to ICAM-1, LFA-1, and IL-10) immunomodulation in the prolongation of skin allografts after antigen-specific pretransplant immunization or transfusion. J Immunol 1994; 152: 2011.
10. Van Twuyver E, Mooijaart RJ, ten Berge IJ, et al. Pretransplantation blood transfusion revisited. N Engl J Med 1991; 325: 1210.
11. Van der Mast BJ, Vietor HE, van der Meer-Prins EM, et al. Modulation of the T cell compartment by blood transfusion: effect on cytotoxic and helper T lymphocyte precursor frequencies and T cell receptor Vbeta usage. Transplantation 1997; 63: 1145.
12. Young NT, Roelen DL, Iggo N, et al. Effect of one-HLA-haplo-type-matched and HLA-mismatched blood transfusions on recipient T lymphocyte allorepertoires. Transplantation 1997; 63: 1160.
13. Lagaaij EL, Ruigrok MB, van Rood JJ, et al. Blood transfusion induced changes in cell-mediated lympholysis: to immunize or not to immunize. J Immunol 1991; 147: 3348.
14. Van Twuyver E, Mooijaart RJ, ten Berge IJ, et al. High-affinity cytotoxic T lymphocytes after non-HLA-sharing blood transfusion: the other side of the coin. Transplantation 1994; 57: 1246.
15. Baudouin V, De Vitry N, Hiesse C, et al. Cytotoxic T lymphocyte changes after HLA-DR match and HLA-DR mismatch blood transfusions. Transplantation 1997; 63: 1155.
16. Vandekerckhove BA, Datema G, Zantvoort F, Claas FH. An increase of donor-specific T helper precursors resulting from blood transfusions. Transplantation 1990; 45: 987.
17. Danzer SG, Kirchner H, Rink L. Cytokine interactions in human mixed lymphocyte culture. Transplantation 1994; 57: 1638.
18. Kaminski ER, Kaminski A, Bending MR, et al. In vitro cytokine profiles and their relevance to rejection following renal transplantation. Transplantation 1995; 60: 703.
19. Van Besouw NM, Daane CR, Vaessen LM, et al. Different patterns in donor-specific production of T-helper 1 and 2 cytokines by cells infiltrating the rejecting cardiac allograft. J Heart Lung Transplant 1995; 14: 816.
20. Michon J, Sterkers G, Haziot A, et al. Despite lack of monospecific anti-DRw13 sera, a corresponding class II determinant can be defined by a DRw13 restricted anti-influenza virus T cell clone. Hum Immunol 1986; 15: 272.
21. Sterkers G, Michon J, Henin Y, Gomard E, Hannoun C, Levy JP. Fine specificity analysis of human influenza-specific cloned cell lines. Cell Immunol 1985; 94: 394.
22. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Ann Biochem 1987; 162: 156.
23. Matthes T, Werner-Favre C, Tang H, Zhang X, Kindler V, Zubler RH. Cytokine mRNA expression during an in vitro response of human B lymphocytes: kinetics of B cell tumor necrosis factor alpha, interleukin (IL)6, IL-10, and transforming growth factor beta 1 mRNAs. J Exp Med 1993; 178: 521.
24. Tang H, Matthes T, Carballido-Perrig N, Zubler RH, Kindler V. Differential induction of T cell cytokine mRNA in Epstein-Barr virus-transformed B cell clones: constitutive and inducible expression of interleukin-4 mRNA. Eur J Immunol 1993; 23: 899.
25. Benjamin D, Hartmann DP, Bazar LS, Jacobson RJ, Gilmore MS. Human B cell lines can be triggered to secrete an interleukin 2-like molecule. Cell Immunol 1989; 121: 30.
26. Gaston JS, Rickinson AB, Epstein MA. Cross-reactivity of self-HLA-restricted Epstein-Barr virus-specific cytotoxic T lymphocytes for allo-HLA determinants. J Exp Med 1983; 158: 1804.
27. Burrows SR, Khanna R, Burrows JM, Moss DJ. An alloresponse in humans is dominated by cytotoxic T lymphocytes (CTL) cross-reactive with a single Epstein-Barr virus CTL epitope: implications for graft-versus-host disease. J Exp Med 1994; 179: 1155.
28. Burrows SR, Silins SL, Khanna R, et al. Cross-reactive memory T cells for Epstein-Barr virus augment the alloresponse to common human leukocyte antigens: degenerate recognition of major histocompatibility complex-bound peptide by T cells and its role in alloreactivity. Eur J Immunol 1997; 27: 1726.
29. Schanz U, Roelen DL, Bruning JW, Kardol MJ, Van Rood JJ, Claas FH. The relative radioresistance of interleukin-2 production by human peripheral blood lymphocytes: consequences for the development of a new limiting dilution assay for the enumeration of helper T lymphocyte precursor frequencies. J Immunol Methods 1994; 177: 269.
30. Young NT, Roelen DL, Dallman MJ, Whood KJ, Morris PJ, Welsh KI. Enumeration of human alloreactive helper T lymphocyte precursor frequencies by limiting dilution analysis of interleukin-2 production. J Immunol Methods 1996; 195; 33.
31. Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 1986; 136: 2348.
32. Fiorentino DF, Fond MW, Mosmann TR. Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med 1989; 170: 2081.
33. Andersson U, Andersson J, Lindfors A, Wagner K, Möller G, Heusser CH. Simultaneous production of interleukin 2, interleukin 4 and interferon-gamma by activated human blood lymphocytes. Eur J Immunol 1990; 20: 1591.
34. Jung T, Schauer U, Heusser C, Neumann C, Rieger C. Detection of intracellular cytokines by flow cytometry. J Immunol Methods 1993; 159: 197.
35. Bejarano MT, De Waal Malefyt R, Abrams JS, et al. Interleukin 10 inhibits allogeneic proliferative and cytotoxic T cell responses generated in primary mixed lymphocyte cultures. Int Immunol 1992; 4: 1389.
36. Toungouz M, Denys C, de Groote D, Andrien M, Dupont E. Optimal control of interferon-γ and tumor necrosis factor-α by interleukin-10 produced in response to one HLA-DR mismatch during the primary mixed lymphocyte reaction. Transplantation 1996; 61: 497.
37. Chen N, Gao Q, Field EH. Expansion of memory Th2 cells over Th1 cells in neonatal primed mice. Transplantation 1995; 60: 1187.
38. Takeuchi T, Lowry RP, Konieczny B. Heart allografts in murine systems: the differential activation of Th2-like effector cells in peripheral tolerance. Transplantation 1992; 53: 1281.
39. Bugeon L, Cuturi MC, Paineau J, Chabannes D, Soulillou JP. Decreased IFN-gamma and IL-2 mRNA expression in peripheral tolerance to heart allografts with conserved granzyme A, perform and MHC antigens mRNA expression. Transplant Proc 1993; 25: 314.
40. + T cells in vivo: differential expression of IL-2 and IL-4 mRNA in recipients of cardiac allografts. J Immunol 1992; 148: 1308.
41. Hancock WW, Sayegh MH, Kwok CA, Weiner HL, Carpenter CB. Oral, but not intravenous, alloantigen prevents accelerated allograft rejection by selective intragraft Th2 cell activation. Transplantation 1993; 55: 1112.
42. Mohler KM, Streilein JW. Lymphokine production by MLR-reactive reaction lymphocytes obtained from normal mice and mice rendered tolerant of class II MHC antigens. Transplantation 1989; 47: 625.
43. Kirkley SA, Cowles J, Pellegrini VD Jr, Harris CM, Boyd AD, Blumberg N. Cytokine secretion after allogeneic or autologous blood transfusion. Lancet 1995; 345: 527.
44. Gafter U, Kalechman, Y, Sredni B. Blood transfusion enhances production of T-helper-2 cytokines and transforming growth factor beta in humans. Clin Sci 1996; 91: 519.